Dr. Douglas Stigge Optometrist Optometrist Medicare: Not Enrolled in Medicare Practice Location: 104 E Commercial St, Waterville, KS 66548 Phone: 785-363-2425 Fax: 785-363-2425 |
News Archive
The re-introduction of measles, mumps and other previously eradicated diseases to the United States is nothing short of a public health crisis. Since Jan. 1, a staggering 880 individual cases of measles have been confirmed in 24 states - the greatest number of cases since 1994. Measles was declared eliminated in the U.S. in 2000.
Tumors have an arsenal of tricks to help them sidestep the immune system. A study published on September 19 in the Journal of Experimental Medicine reveals a new trickāthe ability to keep tumor-fighting T cells out by disabling a T cell-attracting protein within the tumor core.
Human Genome Sciences, Inc. and Aegera Therapeutics, Inc. today announced that HGS has initiated dosing in a Phase 1 clinical trial to evaluate the safety and tolerability of its lead IAP inhibitor, HGS1029, as monotherapy in patients with advanced lymphoid tumors.
New research evaluating the effectiveness of a broad selection of popular slimming supplements sold in pharmacies and health food shops has found no evidence that any of them facilitate weight loss beyond the placebo effect.
After comparing how infections from SARS-CoV-2 (which causes COVID-19) and two other human coronaviruses develop in cynomolgus macaques, researchers report that SARS-CoV-2 gives the animals a mild COVID-19-like disease.
› Verified 2 days ago